Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Status:
Terminated
Trial end date:
2014-07-21
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the long-term safety and tolerability of CB-5945 for
the treatment of opioid-induced constipation (OIC) in adults taking opioid therapy for
chronic non-cancer pain.